ENS@T-CANCER

European Network for the Study of Adrenal Tumours - Structuring clinical research on adrenal cancers in adults

 Coordinatore LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN 

 Organization address address: GESCHWISTER SCHOLL PLATZ 1
city: MUENCHEN
postcode: 80539

contact info
Titolo: Prof.
Nome: Felix
Cognome: Beuschlein
Email: send email
Telefono: +49 89 5160 2110
Fax: +49 89 5160 4467

 Nazionalità Coordinatore Germany [DE]
 Sito del progetto http://www.ensat-cancer.eu/
 Totale costo 8˙122˙828 €
 EC contributo 5˙993˙978 €
 Programma FP7-HEALTH
Specific Programme "Cooperation": Health
 Code Call FP7-HEALTH-2010-two-stage
 Funding Scheme CP-FP
 Anno di inizio 2011
 Periodo (anno-mese-giorno) 2011-01-01   -   2016-06-30

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN

 Organization address address: GESCHWISTER SCHOLL PLATZ 1
city: MUENCHEN
postcode: 80539

contact info
Titolo: Prof.
Nome: Felix
Cognome: Beuschlein
Email: send email
Telefono: +49 89 5160 2110
Fax: +49 89 5160 4467

DE (MUENCHEN) coordinator 318˙574.00
2    INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)

 Organization address address: 101 Rue de Tolbiac
city: PARIS
postcode: 75654

contact info
Titolo: Ms.
Nome: Annick
Cognome: Bertault
Email: send email
Telefono: +33 140 784 901
Fax: +33 140 784 998

FR (PARIS) participant 1˙164˙560.00
3    UNIVERSITA DEGLI STUDI DI TORINO

 Organization address address: Via Giuseppe Verdi 8
city: TORINO
postcode: 10124

contact info
Titolo: Dr.
Nome: Eugenio
Cognome: Rinaldi
Email: send email
Telefono: +39 011 670 5441
Fax: +39 011 670 5413

IT (TORINO) participant 866˙000.00
4    UNIVERSITY OF MELBOURNE

 Organization address address: PARKVILLEOFFICE OF THE VICE CHANCELLOR
city: MELBOURNE
postcode: 3010

contact info
Titolo: Ms.
Nome: Melinda
Cognome: Heron
Email: send email
Telefono: +61 3 8344 2052
Fax: +61 3 8344 5104

AU (MELBOURNE) participant 537˙488.00
5    FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III

 Organization address address: CALLE MELCHOR FERNANDEZ ALMAGRO 3
city: MADRID
postcode: 28029

contact info
Titolo: Ms.
Nome: Lievanes
Cognome: Dolores
Email: send email
Telefono: +34 917 328 000
Fax: +34 912 246 980

ES (MADRID) participant 483˙830.00
6    INSTITUT GUSTAVE ROUSSY

 Organization address address: Rue Camille Desmoulins 39
city: VILLEJUIF
postcode: 94805

contact info
Titolo: Mr.
Nome: Arnauld
Cognome: Forest
Email: send email
Telefono: +33 1 42 11 66 04
Fax: +33 1 42 11 61 50

FR (VILLEJUIF) participant 434˙432.00
7    THE UNIVERSITY OF BIRMINGHAM

 Organization address address: Edgbaston
city: BIRMINGHAM
postcode: B15 2TT

contact info
Titolo: Mr.
Nome: Robert
Cognome: Fekete
Email: send email
Telefono: +44 121 415 8202
Fax: +44 121 414 6056

UK (BIRMINGHAM) participant 425˙124.00
8    ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM

 Organization address address: 's Gravendijkwal 230
city: ROTTERDAM
postcode: 3015CE

contact info
Titolo: Ms.
Nome: Shirley
Cognome: Chan
Email: send email
Telefono: +31 1070 41929
Fax: +31 1070 41023

NL (ROTTERDAM) participant 385˙000.00
9    GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG GAB O

 Organization address address: Oskar-von-Miller-Ring 29
city: MUENCHEN
postcode: 80333

contact info
Titolo: Ms.
Nome: Birgit
Cognome: Fuchs
Email: send email
Telefono: +49 89 288 1040
Fax: +49 89 288 10420

DE (MUENCHEN) participant 319˙146.00
10    STICHTING KATHOLIEKE UNIVERSITEIT

 Organization address address: GEERT GROOTEPLEIN NOORD 9
city: NIJMEGEN
postcode: 6525 EZ

contact info
Titolo: Mr.
Nome: Maarten
Cognome: Van Langen
Email: send email
Telefono: +31 24 3618937
Fax: +31 24 3540529

NL (NIJMEGEN) participant 283˙200.00
11    TECHNISCHE UNIVERSITAET DRESDEN

 Organization address address: HELMHOLTZSTRASSE 10
city: DRESDEN
postcode: 1069

contact info
Titolo: Dr.
Nome: Lars
Cognome: Henning
Email: send email
Telefono: +49 351 463 42185
Fax: +49 351 463 39742

DE (DRESDEN) participant 237˙000.00
12    UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT

 Organization address address: JOSEF-SCHNEIDER-STRASSE 2
city: WUERZBURG
postcode: 97080

contact info
Titolo: Mr.
Nome: Steffen
Cognome: Romstöck
Email: send email
Telefono: +49 931 201 55867
Fax: +49 931 201 61768

DE (WUERZBURG) participant 212˙400.00
13    CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE

 Organization address address: Rue Michel -Ange 3
city: PARIS
postcode: 75794

contact info
Titolo: Dr.
Nome: Hélène
Cognome: Faradji
Email: send email
Telefono: +33 4 939 54190
Fax: +33 4 929 60339

FR (PARIS) participant 187˙624.00
14    UNIVERSITA DEGLI STUDI DI FIRENZE

 Organization address address: Piazza San Marco 4
city: Florence
postcode: 50121

contact info
Titolo: Prof.
Nome: Stefano
Cognome: Milani
Email: send email
Telefono: +39 55 4271465
Fax: +39 55 4222409

IT (Florence) participant 49˙800.00
15    UNIVERSITA DEGLI STUDI DI PADOVA

 Organization address address: VIA 8 FEBBRAIO 2
city: PADOVA
postcode: 35122

contact info
Titolo: Prof.
Nome: Guiseppe
Cognome: Realdi
Email: send email
Telefono: +39 049 821 8692
Fax: +39 049 821 1886

IT (PADOVA) participant 49˙800.00
16    PHILIPPS UNIVERSITAET MARBURG

 Organization address address: Biegenstrasse 10
city: MARBURG
postcode: 35032

contact info
Titolo: Dr.
Nome: Basenau
Cognome: Sandra
Email: send email
Telefono: 4964210000000
Fax: 4964210000000

DE (MARBURG) participant 40˙000.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

diagnosis    treatment    clinical    ens    identification    acc    centers    patients    tools    progress    cancer    affected    outcome    cancers    adrenal    network       tumors    mph   

 Obiettivo del progetto (Objective)

'Among patients with adrenal masses Adrenocortical carcinoma (ACC) and malignant pheochromocytomas (MPH) are found with a low incidence but very unfavorable prognosis. Due to this poor clinical outcome, concomitant hormone dysregulation and limited treatment options the two cancer entities severely impact on affected patients. However, the rarity of the tumors also impedes clinical studies which are affected by fragmentation and low cohort sizes. The European Network for the Study of Adrenal Tumors (ENS@T) has recently implemented a collection of adrenal tumor related databases and defined an associated network of Biological Resource Centers devoted to research on adrenal tumors. The concurrence of recent achievements of this evolving network, the progress in the understanding of molecular mechanisms and increasing availability of specific diagnostic and therapeutic tools for adrenal cancers provides the unique opportunity to achieve unmatched progress in the implementation of both translation and clinical research dedicated to ACC and MPH. Specifically, the newly formed ENS@T-CANCER consortium will address the following topics: 1. Structuring European clinical and translational research through implementation of a virtual research environment, 2. Improving clinical outcome of patients with adrenal cancer by conducting interventional trials carried out by European centers of excellence, 3. Improvement of differential diagnosis and risk stratification of adrenal cancer, 4. Identification and validation of tools for follow-up of patients with adrenal cancer, 5. Identification of novel biomarkers for treatment response. The ultimate aim of the ENS@T-CANCER Consortium is to develop research in the field of adrenal cancers to improve diagnosis and treatment abilities. The Network will allow recruiting sufficient patients in all relevant European centers, to harmonize diagnosis criteria and to use the various technological approaches of a number of laboratories.'

Introduzione (Teaser)

To improve diagnosis and treatment of adrenal tumours, a European network is bringing basic research into clinical care for patients with rare adrenal cancers. Today, the only known curative treatment is surgical removal of the tumour.

Altri progetti dello stesso programma (FP7-HEALTH)

CANCERALIA (2011)

Development of novel diagnostic and therapeutic approaches to improve patient outcome in lung and pancreatic tumours

Read More  

BETACURE (2014)

Personalized diagnosis and treatment of hyperinsulinemic hypoglycaemia caused by beta-cell pathology

Read More  

HYPORTH (2013)

New approaches in the development of Hypoallergenic implant material in Orthopaedics: steps to personalised medicine

Read More